Matrix-m

Matrix-m has been studied in 1 paper since 2022: none in people yet, 1 review. No study of it in people or animals has been published yet. The newest paper, Apr 20, 2022: “Precision Vaccine Adjuvants for Older Adults: A Scoping Review”.

Intervention

1 paper studies itUpdated

See all 1 papers on matrix-m

At a glance

3 trials, none about aging.

Cells, worms or flies, mice and humans: nothing yet.
  • 3 trials, none about aging
  • 1 of 3 trials sponsored by its developers

Who is developing matrix-m?

2 companies: Sanofi and Novavax.

Companies

Trial sponsors

Latest